Board of Directors
Rick Doblin, Ph.D., Founder and President
Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs.…
Amy Emerson, Chief Executive Officer at Lykos Therapeutics
Amy Emerson is the Chief Executive Officer at Lykos Therapeutics is a Delaware public benefit corporation with the special purpose to balance income from legal sales of MDMA with the social benefits of MAPS’ mission. MAPS is a majority shareholder of Lykos Therapeutics. Amy started as a pro bono consultant at MAPS in 2003, and…
David Bronner, Board of Directors
Independent Voting Member David Bronner is Cosmic Engagement Officer (CEO) of Dr. Bronner’s, the top-selling brand of natural soaps in North America and producer of a range of organic body care and food products. He is a grandson of company founder, Emanuel Bronner, and a fifth-generation soapmaker. David and Michael established Dr. Bronner’s as a…
Staff
Rick Doblin, Ph.D., Founder and President
Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs.…
Kris Lotlikar, Executive Director
Kris Lotlikar serves as the Executive Director of MAPS, overseeing financing and strategic direction of MAPS’ organizations globally. Since joining the MAPS, Kris helped shepherd Lykos Therapeutics into the leading psychedelic drug development company, raising over $100 million for MAPS and Lykos Therapeutics. Kris’s passion and expertise is in building high-performing organizations in nascent and…
Fede Menapace, Deputy Director
Fede serves as the Deputy Director for the Multidisciplinary Association for Psychedelic Studies (MAPS) where he oversees day-to-day operations and supports the MAPS team in developing and achieving our strategic priorities. Fede also helps guide MAPS subsidiaries on governance and financing matters. Born and raised in the Trentino region in northern Italy, he began his…
Lykos Therapeutics
Lykos Therapeutics is a Delaware public benefit corporation with the special purpose to balance income from legal sales of MDMA with the social benefits of MAPS’ mission. MAPS is a majority shareholder of Lykos. https://lykospbc.com/